-63%

est. 2Y upside i

HealthcareSeries D+

Unlocking the power of biotech with modern software for modern science

Rank

#3423

Sector

Biotechnology SaaS

Est. Liquidity

~2Y

Data Quality

Data: Medium

Benchling's equity offers poor upside prospects over a 2-year horizon due to a high entry multiple (15x secondary) relative to public comps (5-12x) and modest decaying growth (27% YoY).

Last updated: July 3, 2026

Bull (10%)-23%

If an IPO window opens within 2 years and category leadership drives multiple towards 12x, projected revenue $335M yields $4.02B exit, but after 20% dilution and entry at $4.15B, net negative 23.2%.

Base (45%)-55%

Exit multiple converges to 8x (mid of comps 5-12x), yielding $2.68B exit; after 20% dilution, common stock loses over half of value.

Bear (45%)-80%

Multiple compresses to 5x due to incumbent pressure and slowing growth, exit $1.67B; after 20% dilution, near-total loss.

Est. time to liquidity~2.0 years

Preference Stack Risk

moderate

Funding Intensity

990%

Total funding of $412M on $4.15B entry valuation represents a 9.9% preference overhang; non-participating preferred means common gets residual after 1x liquidation preference.

Dilution Risk

high

Likely raise within 24 months given cash burn and stale round; estimated 20% dilution from a potential down round.

Secondary Liquidity

limited

Secondary implied valuation ($4.15B) is 32% below primary round, indicating limited near-term liquidity for shareholders.

Engineering — 21 roles

Product & Design — 11 roles

Customer Experience — 7 roles

Marketing — 2 roles

Finance — 1 role

People — 1 role

View all 56 open roles at Benchling →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Benchling's data — designed to show you've done your homework.

  • 1

    “How does Benchling plan to defend against Veeva's integrated R&D cloud and maintain its competitive moat?”

  • 2

    “What are the current unit economics (LTV/CAC) and how do they evolve as the company scales?”

  • 3

    “Given the secondary valuation markdown of 32% from the primary round, what is the board's plan for achieving liquidity (IPO, acquisition)?”

Community

Valuation Sentiment

Our model estimates -63% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.